Pfizer said on Tuesday it is seeking US authorisation of its experimental antiviral Covid-19 pill that cut the chance of hospitalisation or death for adults at risk of severe disease by 89% in a clinical trial. <br /><br />WATCH MORE: https://thestartv.com/c/news<br />SUBSCRIBE: https://cutt.ly/TheStar<br />LIKE: https://fb.com/TheStarOnline
